Nutriband (NASDAQ:NTRBW) Shares Down 9.7% – Should You Sell?

Shares of Nutriband Inc. (NASDAQ:NTRBW) fell 9.7% on Thursday . The company traded as low as $1.40 and last traded at $1.40. 8,275 shares were traded during mid-day trading, an increase of 183% from the average session volume of 2,922 shares. The stock had previously closed at $1.55.

Nutriband Stock Performance

The business has a 50 day moving average of $1.56 and a 200 day moving average of $1.71.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nutriband stock. Empery Asset Management LP acquired a new stake in shares of Nutriband Inc. (NASDAQ:NTRBW) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband accounts for approximately 0.1% of Empery Asset Management LP’s investment portfolio, making the stock its 20th biggest position.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.